Compared to the low-expression group, HNSCC high-expression samples showed reduced PDCD1LG2 and CD276 expression, while BRCA high-expression samples showed decreased CD274 and PDCD1LG2 levels. This evidence concerns the gene PDCD1LG2 and head and neck squamous cell carcinoma.